Long-Acting PrEP: Strategies to Support PrEP Persistence and Reengagement

CCO Infectious Disease Podcast

English - January 10, 2024 19:21 - 29 minutes - 27.3 MB
Courses Education Science Life Sciences hiv covid-19 cme hepatitis b hbv id medical education coronavirus hepatitis c hcv Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: RSV Vaccines in Adults: A Risk-Based Approach

Next Episode: Why I Started and Why I Stayed on HIV PrEP

In this episode, Sarah M. Wood, MD, MS, discusses data and recommendations for long-acting pre-exposure prophylaxis (PrEP) as a strategy to support PrEP persistence and engagement for adolescents, including:

The PrEP care continuum for adolescentsSystem barriers to PrEP coverage and privacy concerns for adolescentsThe benefits and challenges of same-day PrEP initiation and real-world data to support itInterventions to support PrEP persistencePrEP options for different populations and the data to support the efficacy of long-acting cabotegravir (CAB) PrEP from HPTN 083 and HPTN 084Data and recommendations for a CAB PrEP oral lead-inData from HPTN 083 showing no interaction between feminizing hormone therapy and long-acting CAB PrEPProject LifeSkills: a culturally specific, empowerment-based, group-delivered behavioral HIV prevention intervention for young transgender women

Faculty

Sarah M. Wood, MD, MS
Assistant Professor of Pediatrics
Division of Adolescent Medicine
Perelman School of Medicine
University of Pennsylvania
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Follow along with the slides:
https://bit.ly/3Ha9Kmt

Link to full program:
https://bit.ly/3ZlICsL

To automatically get new episodes as soon as they launch, subscribe to the CCO Infectious Disease podcast show.